Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

46 recalls, newest first

Class II · Moderate risk

Avant Foaming Hand Sanitizer

CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.

Terminated Microbial contamination Aire-Master of America Inc D-1355-2022
Class I · High risk

SnoreStop NasoSpray

Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.

Terminated Microbial contamination Green Pharmaceuticals, Inc. NDC 61152-199-99 D-1165-2022
Class II · Moderate risk

Earache Drops

Microbial contamination of non-sterile product.

Terminated Microbial contamination Grato Holdings, Inc. NDC 0363-3233-15 D-0991-2022
Class II · Moderate risk

Zonisamide Capsules USP

CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.

Terminated Microbial contamination Direct Rx NDC 61919-775-90 D-0888-2022
Class II · Moderate risk

Milk of Magnesia USP

CGMP Deviations: Failure to properly investigate failed microbial testing.

Completed Microbial contamination Plastikon Healthcare LLC NDC 0904-6846-73 D-0870-2022
Class I · High risk

Hcg 6

Non-sterility; bacterial contamination identified as Paenibacillus lautus.

Terminated Microbial contamination Revive Rx LLC dba Revive Rx Pharmacy D-0648-2022
Class I · High risk

Revitaderm Wound Care Gel

Microbial Contamination of Non-sterile Product; FDA analysis found the product to be contaminated with Bacillus cereus.

Terminated Microbial contamination Blaine Labs Inc NDC 63347-120-02 D-0668-2022

Recalls by year